Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR Screen Reveals BRD2/4 Molecular Glue-like Degrader via Recruitment of DCAF16
Andrea G. Shergalis, Violeta L. Marin, David Y. Rhee, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 2, pp. 331-339
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Rational Chemical Design of Molecular Glue Degraders
Ethan S. Toriki, James W. Papatzimas, Kaila Nishikawa, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 915-926
Open Access | Times Cited: 87
Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 87
Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 83
Targeted protein degradation via intramolecular bivalent glues
Oliver Hsia, Matthias Hinterndorfer, Angus D. Cowan, et al.
Nature (2024) Vol. 627, Iss. 8002, pp. 204-211
Open Access | Times Cited: 72
From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation
Vladas Oleinikovas, Pablo Gaínza, Thomas Ryckmans, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 291-312
Open Access | Times Cited: 51
Molecular glues for protein-protein interactions: Progressing toward a new dream
Markella Konstantinidou, Michelle R. Arkin
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1064-1088
Open Access | Times Cited: 25
DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders
Melissa Lim, Thang Do Cong, Lauren M. Orr, et al.
ACS Central Science (2024) Vol. 10, Iss. 7, pp. 1318-1331
Open Access | Times Cited: 22
Applications of protein ubiquitylation and deubiquitylation in drug discovery
Yilin Chen, Haoan Xue, Jianping Jin
Journal of Biological Chemistry (2024) Vol. 300, Iss. 5, pp. 107264-107264
Open Access | Times Cited: 16
The rise of degrader drugs
Mingxing Teng, Nathanael S. Gray
Cell chemical biology (2023) Vol. 30, Iss. 8, pp. 864-878
Open Access | Times Cited: 27
Chemical Specification of E3 Ubiquitin Ligase Engagement by Cysteine-Reactive Chemistry
Roman C. Sarott, Inchul You, Yen-Der Li, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 40, pp. 21937-21944
Closed Access | Times Cited: 26
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 24
Template-assisted covalent modification underlies activity of covalent molecular glues
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
Nature Chemical Biology (2024)
Open Access | Times Cited: 14
A small molecule VHL molecular glue degrader for cysteine dioxygenase 1
Antonin Tutter, Dennis L. Buckley, Andrei A. Golosov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10
Molecular glue degraders: exciting opportunities for novel drug discovery
Thomas Lemaître, Marie Cornu, Florian Schwalen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 433-449
Closed Access | Times Cited: 8
Emerging strategies for prospective discovery of molecular glue degraders
Baiyun Wang, Shiyun Cao, Ning Zheng
Current Opinion in Structural Biology (2024) Vol. 86, pp. 102811-102811
Closed Access | Times Cited: 8
Targeted Protein Degradation: Current and Emerging Approaches for E3 Ligase Deconvolution
Yufeng Xiao, Yaxia Yuan, Yi Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 8
Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases
Priyanka Dey Talukdar, Urmi Chatterji
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Targeted protein degradation via intramolecular bivalent glues
Oliver Hsia, Matthias Hinterndorfer, Angus D. Cowan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 19
Breaking Bad Proteins—Discovery Approaches and the Road to Clinic for Degraders
Corentin Bouvier, Rachel Lawrence, Francesca Cavallo, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 578-578
Open Access | Times Cited: 7
Molecular glues and induced proximity: An evolution of tools and discovery
Stephanie Anne Robinson, J Co, Steven M. Banik
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1089-1100
Closed Access | Times Cited: 7
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation
Chrysanthi Kagiou, José A. Cisneros, Jakob Farnung, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues
Muhammad Murtaza Hassan, Yen-Der Li, W Michelle, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116904-116904
Open Access | Times Cited: 7
An updated patent review of BRD4 degraders
Zonghui Ma, Cun Zhang, Andrew A. Bolinger, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 929-951
Closed Access | Times Cited: 6
Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity
Jiantao Hu, Biao Hu, Fuming Xu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8222-8237
Closed Access | Times Cited: 14
Selective degradation of BRD9 by a DCAF16-recruiting targeted glue: mode of action elucidation and in vivo proof of concept
Scott J. Hughes, Wojciech J. Stec, Colin Davies, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Page 1 - Next Page

Scroll to top